Ghrelin offers triple benefits for heart failure: GH-mediated cardiac improvement, appetite stimulation to combat cachexia, and direct cardioprotection through cardiac GHS receptors — a unique multi-mechanism treatment.
Triple cardiac benefitOne peptide addresses three heart failure problems: weak pumping (GH), muscle wasting (appetite), and cell damage (direct protection)
What the researchers found
Ghrelin provides triple-mechanism benefit for heart failure: GH-mediated cardiac improvement, appetite stimulation counteracting cachexia, and direct GHS-R-mediated cardioprotection — addressing three core disease components.
Why it matters
Heart failure treatments typically target only one mechanism. Ghrelin simultaneously addresses cardiac dysfunction, wasting, and cellular damage — a comprehensive single-agent approach.
How the study worked
Review of ghrelin's cardiac, metabolic, and direct cardioprotective effects with application to heart failure therapy.
What this study cannot tell us
Review of largely preclinical data. Human heart failure trials with ghrelin were limited at time of publication.
How to read the evidence
Moderate evidence from a review integrating preclinical cardiac, metabolic, and protective data.
When this study was published
Published in 2003. Ghrelin has been tested in small human heart failure trials with encouraging results.
The bigger picture
Heart failure is a multi-system disease requiring multi-mechanism treatment. Ghrelin's triple action addresses cardiac, metabolic, and cellular components simultaneously.
Questions still open
- Can chronic ghrelin therapy improve heart failure outcomes?
- Does the appetite increase help or harm in heart failure?
- Which ghrelin mechanism is most important for cardiac benefit?
Common questions
How can a hunger hormone help heart failure?
Is this being tested in patients?
Read the original research
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure.
Regulatory peptides, 114(2-3), 71-7
Citation
Nagaya, Noritoshi; Kangawa, Kenji. (2003). Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure.. Regulatory peptides, 114(2-3), 71-7.